Ke Wang

nanjing medical university

H指数:20

被引数:1,445

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of surgical outcomes between lateral and posterior methods for retroperitoneoscopic adrenalectomy: insights from a single center's experience

腹腔镜肾上腺切除术侧方与后方入路手术结果的比较：来自单中心经验的启示

Frontiers in Oncology

IF3.3

2026-02-100

PRE

A population-based analysis of a risk stratification system for predicting radiotherapy benefits in invasive breast carcinoma of no special type with medullary pattern

基于人群的分析：一种用于预测无特殊类型浸润性乳腺癌髓样型放疗获益的风险分层系统

European Journal of Medical Research

IF3.4

2025-12-020

OAAI

Zanidatamab in combination with docetaxel in first-line HER2-positive breast cancer: results from an open-label, multicenter, phase Ib/II study

Zanidatamab联合多西他赛在一线HER2阳性乳腺癌中的应用：一项开放标签、多中心、 Ib/II期研究的结果

ESMO Open

IF8.3

2025-11-060

OAAI

Multilingual capital, teacher agencies, and learner identities: co-constructive reflexive narratives on Mandarin Chinese speakers in language and intercultural education

多语资本、教师代理机构和学习者身份：关于语言与跨文化教育中普通话使用者的共构反思叙事

International Journal of Educational Management

IF2.4

2025-10-011

PRE

Construction of a radiogenomic signature based on endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma

BMC CANCER

IF3.4

2025-01-231

OAAI

Identifying core symptom clusters based on symptom distress levels in patients with maintenance hemodialysis: a cross-sectional network analysis

RENAL FAILURE

IF3

2025-01-130

OAAI

The IL-1β/STAT1 Axis inhibits STAT3 function via Sequestration of the transcriptional activator GLIS2, leading to postoperative vascular dysfunction

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-12-010

PRE

CISD3 is a prognostic biomarker and therapeutic target in pan-cancer

CISD3是泛癌症的预后生物标志物和治疗靶点

SCIENTIFIC REPORTS

IF3.9

2024-10-081

OAAI

MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation

NATURE COMMUNICATIONS

IF15.7

2024-02-294

OAAI

Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer

BREAST CANCER

IF2.9

2023-02-021

PRE

Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing

通过RNA测序在三阴性乳腺癌中鉴定出的新生物标志物

CLINICA CHIMICA ACTA

IF2.9

2022-06-017

PRE

TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models

TNF拮抗剂在胶原诱导的关节炎小鼠模型中使滑膜成纤维细胞对铁吞噬细胞死亡敏感

NATURE COMMUNICATIONS

IF15.7

2022-02-03143

OAAI

Chitosan-tripolyphosphate nanoparticles-mediated co-delivery of MTHFD1L shRNA and 5-aminolevulinic acid for combination photodynamic-gene therapy in oral cancer

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2021-12-0127

OAAI

Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2021-08-0117

OAAI

A nomogram based on clinicopathological features and serological indicators predicting breast pathologic complete response of neoadjuvant chemotherapy in breast cancer

SCIENTIFIC REPORTS

IF3.9

2021-05-316

OAAI

Carrier-Free Immobilization of α-Galactosidase as Nano-Biocatalysts for Synthesizing Prebiotic α-Galacto-Oligosaccharides

无载体固定化 α-半乳糖苷酶纳米生物催化剂合成益生元 α-低聚半乳糖

MOLECULES

IF4.6

2021-02-255

OAAI

Sodium vitamin C transporter 2 orchestrates lactate metabolism in mouse Sertoli cells

JOURNAL OF MOLECULAR ENDOCRINOLOGY

IF3.8

2021-02-012

An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B

AGING-US

IF3.9

2020-12-263

OAAI

The Double-Edged Sword of Immunosuppressive Therapy in Kidney Transplantation: A Rare Case Report of Pulmonary Mucormycosis Post-Transplant and Literature Review

FRONTIERS IN MEDICINE

IF3

2020-09-235

OAAI

Production of ACE inhibitory peptides from corn germ meal by an enzymatic membrane reactor with a novel gradient diafiltration feeding working-mode and in vivo evaluation of antihypertensive effect

JOURNAL OF FUNCTIONAL FOODS

IF4

2020-01-0139

OAAI

Ke Wang

个人简介

教育背景

工作经历

荣誉奖项

研究方向